Get startedLog in
    Picture of SynAct Pharma AB logo

    SYNACT — SynAct Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Synact Pharma To Carry Out Directed Issues, Fully Guaranteed Rights Issue

    Picture of SynAct Pharma AB logoSynAct Pharma AB
    20/11/2024 09:15
    Nov 20 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * INTENDS TO CARRY OUT DIRECTED ISSUES TOTALLING
APPROXIMATELY 45
MSEK AND A FULLY GUARANTEED RIGHTS ISSUE TOTALLING APPROXIMATELY
20 MSEK
    * SUBSCRIPTION PRICE OF 8.65 SEK PER SHARE

Source text:  ID:nMFN5smnfp 
Further company coverage:  SYNACT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on SynAct Pharma AB

    See all news